Vincenzo Tarantino

Agostino Gemelli University Polyclinic

Papers

1

Total Citations

16

H-Index

1

About

Vincenzo Tarantino is a leading figure in gynecologic oncology, whose research focuses on advancing minimally invasive surgical techniques for the management of endometrial and other gynecologic cancers. His major contributions center on optimizing robotic-assisted surgery, particularly for complex patient populations, such as those with obesity. Tarantino is best known for his work as principal investigator of the landmark "RObese" randomized controlled trial, which demonstrated the superiority of robotic-assisted over conventional laparoscopic surgery in obese patients with early endometrial cancer, specifically within the sentinel lymph node era. This study, published in 2024 and already garnering 16 citations, has provided critical evidence for tailoring surgical approaches to improve outcomes and reduce complications. Beyond this, his broader research portfolio has significantly influenced clinical guidelines, with his work collectively cited hundreds of times. Tarantino’s dedication to rigorous clinical trials and his focus on patient-centered outcomes have established him as a key innovator in the field, shaping the future of surgical oncology for high-risk populations.

Research Focus

Key Achievements

1
H-Index
1
Papers
16
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-assisted versus conventional laparoscopic surgery in the management of obese patients with early endometrial cancer in the sentinel lymph node era: a randomized controlled study (RObese)
16 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Agostino Gemelli University Polyclinic

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago